{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:50:02Z","timestamp":1787316602869,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"FEDER-UCLM","award":["UCLM 2022"],"award-info":[{"award-number":["UCLM 2022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42949-3","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:36:07Z","timestamp":1772631367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Physical and respiratory training in patients with myasthenia gravis: a systematic review with meta-analysis"],"prefix":"10.1038","volume":"16","author":[{"given":"Guillermo","family":"Gutierrez-Del-Val","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Serrano-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Mazoteras-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Molina-Madue\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Bouzas-Mosquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Carmona-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Alberto","family":"Laredo-Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"42949_CR1","doi-asserted-by":"crossref","unstructured":"Fu, Y. et al. Breaking barriers: advancing cellular therapies in autoimmune disease management. Front. Immunol. 15, (2024).","DOI":"10.3389\/fimmu.2024.1503099"},{"key":"42949_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.12691\/ijcd-3-4-8","volume":"3","author":"A Lerner","year":"2016","unstructured":"Lerner, A., Jeremias, P. & Matthias, T. The World Incidence and Prevalence of Autoimmune Diseases is Increasing. Int. J. Celiac Disease. 3, 151\u2013155 (2016).","journal-title":"Int. J. Celiac Disease"},{"key":"42949_CR3","doi-asserted-by":"publisher","first-page":"102266","DOI":"10.1016\/j.coi.2022.102266","volume":"80","author":"FW Miller","year":"2023","unstructured":"Miller, F. W. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr. Opin. Immunol. 80, 102266 (2023).","journal-title":"Curr. Opin. Immunol."},{"key":"42949_CR4","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.3390\/cells12202456","volume":"12","author":"M Oeztuerk","year":"2023","unstructured":"Oeztuerk, M. et al. Current Biomarker Strategies in Autoimmune Neuromuscular Diseases. Cells 12, 2456 (2023).","journal-title":"Cells"},{"key":"42949_CR5","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1038\/s41598-024-54413-1","volume":"14","author":"WJ Choi","year":"2024","unstructured":"Choi, W. J. et al. Global carrier frequency and predicted genetic prevalence of patients with pathogenic sequence variants in autosomal recessive genetic neuromuscular diseases. Sci. Rep. 14, 3806 (2024).","journal-title":"Sci. Rep."},{"key":"42949_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.semerg.2018.01.003","volume":"44","author":"S Mart\u00ednez Torre","year":"2018","unstructured":"Mart\u00ednez Torre, S. & G\u00f3mez Molinero, I. Mart\u00ednez Gir\u00f3n, R. Puesta al d\u00eda en la miastenia gravis. Med. de Familia SEMERGEN. 44, 351\u2013354 (2018).","journal-title":"Med. de Familia SEMERGEN"},{"key":"42949_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.nrl.2020.06.011","volume":"38","author":"DA Garc\u00eda Est\u00e9vez","year":"2023","unstructured":"Garc\u00eda Est\u00e9vez, D. A. et al. Epidemiolog\u00eda de la miastenia gravis en la provincia de Ourense (Galicia, noroeste de Espa\u00f1a). Neurolog\u00eda 38, 75\u201381 (2023).","journal-title":"Neurolog\u00eda"},{"key":"42949_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12967-021-03185-7","volume":"19","author":"N Salari","year":"2021","unstructured":"Salari, N. et al. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis. J. Transl Med. 19, 516 (2021).","journal-title":"J. Transl Med."},{"key":"42949_CR9","doi-asserted-by":"publisher","first-page":"e16367","DOI":"10.1016\/j.heliyon.2023.e16367","volume":"9","author":"G Antonini","year":"2023","unstructured":"Antonini, G. et al. Real world study on prevalence, treatment and economic burden of myasthenia gravis in Italy. Heliyon 9, e16367 (2023).","journal-title":"Heliyon"},{"key":"42949_CR10","doi-asserted-by":"publisher","unstructured":"Luisa Antelo, M. et al. An\u00e1lisis de costes del tratamiento con recambio plasm\u00e1tico terap\u00e9utico frente al tratamiento con inmunoglobulinas endovenosas en pacientes con enfermedades neurol\u00f3gicas de base inmune. Propuesta de optimizaci\u00f3n del uso de hemoderivados plasm\u00e1ticos. Neurolog\u00eda. https:\/\/doi.org\/10.1016\/j.nrl.2023.08.002 (2024).","DOI":"10.1016\/j.nrl.2023.08.002"},{"key":"42949_CR11","doi-asserted-by":"crossref","unstructured":"Piehl, F. et al. Economic and societal burden of myasthenia gravis in Denmark, Finland, and Sweden: A population-based registry study. Eur. J. Neurol. 31, (2024).","DOI":"10.1111\/ene.16511"},{"key":"42949_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00415-009-5256-6","volume":"257","author":"K Schepelmann","year":"2010","unstructured":"Schepelmann, K. et al. Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J. Neurol. 257, 15\u201323 (2010).","journal-title":"J. Neurol."},{"key":"42949_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nrl.2015.02.003","volume":"33","author":"A Camacho","year":"2018","unstructured":"Camacho, A., Esteban, J. & Paradas, C. Informe de la Fundaci\u00f3n Del Cerebro sobre el impacto social de la esclerosis lateral amiotr\u00f3fica y las enfermedades neuromusculares. Neurolog\u00eda 33, 35\u201346 (2018).","journal-title":"Neurolog\u00eda"},{"key":"42949_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.medcli.2023.04.006","volume":"161","author":"DA Garc\u00eda Est\u00e9vez","year":"2023","unstructured":"Garc\u00eda Est\u00e9vez, D. A. Pardo Fern\u00e1ndez, J. Miastenia gravis. Actualizaci\u00f3n diagn\u00f3stica y terap\u00e9utica. Med. Clin. (Barc). 161, 119\u2013127 (2023).","journal-title":"Med. Clin. (Barc)"},{"key":"42949_CR15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50017","author":"AK Mishra","year":"2023","unstructured":"Mishra, A. K., Varma, A. & Myasthenia Gravis Syst. Rev. Cureus https:\/\/doi.org\/10.7759\/cureus.50017 doi:10.7759\/cureus.50017. (2023).","journal-title":"Syst. Rev. Cureus"},{"key":"42949_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.autrev.2017.11.010","volume":"17","author":"K Sharif","year":"2018","unstructured":"Sharif, K. et al. Physical activity and autoimmune diseases: Get moving and manage the disease. Autoimmun. Rev. 17, 53\u201372 (2018).","journal-title":"Autoimmun. Rev."},{"key":"42949_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jshs.2024.02.002","volume":"13","author":"B Luo","year":"2024","unstructured":"Luo, B. et al. The anti-inflammatory effects of exercise on autoimmune diseases: A 20-year systematic review. J. Sport Health Sci. 13, 353\u2013367 (2024).","journal-title":"J. Sport Health Sci."},{"key":"42949_CR18","doi-asserted-by":"publisher","first-page":"103033","DOI":"10.1016\/j.ctim.2024.103033","volume":"81","author":"S Peng","year":"2024","unstructured":"Peng, S. et al. Current state of research on exercise for the treatment of myasthenia gravis: A scoping review. Complement. Ther. Med. 81, 103033 (2024).","journal-title":"Complement. Ther. Med."},{"key":"42949_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nmd.2020.12.004","volume":"31","author":"NE Gilhus","year":"2021","unstructured":"Gilhus, N. E. Physical training and exercise in myasthenia gravis. Neuromuscul. Disord. 31, 169\u2013173 (2021).","journal-title":"Neuromuscul. Disord."},{"key":"42949_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/jfmk5040071","volume":"5","author":"B Corrado","year":"2020","unstructured":"Corrado, B., Giardulli, B. & Costa, M. Evidence-Based Practice in Rehabilitation of Myasthenia Gravis. A Systematic Review of the Literature. J. Funct. Morphol. Kinesiol. 5, 71 (2020).","journal-title":"J. Funct. Morphol. Kinesiol."},{"key":"42949_CR21","doi-asserted-by":"publisher","first-page":"101593","DOI":"10.1016\/j.rehab.2021.101593","volume":"65","author":"M Cotinat","year":"2022","unstructured":"Cotinat, M., Verschueren, A., Attarian, S., Viton, J. M. & Bensoussan, L. Multidisciplinary rehabilitation is relevant in severe myasthenia gravis: An observation. Ann. Phys. Rehabil Med. 65, 101593 (2022).","journal-title":"Ann. Phys. Rehabil Med."},{"key":"42949_CR22","first-page":"46","volume":"19","author":"M M\u00f3nica","year":"2013","unstructured":"M\u00f3nica, M. & Monasterios, D. Edna Serrano Arancibia, D. C. Miastenia Gravis del Adulto. Rev. Med. La. Paz. 19, 46\u201352 (2013).","journal-title":"Rev. Med. La. Paz"},{"key":"42949_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/mus.25493","volume":"56","author":"E Westerberg","year":"2017","unstructured":"Westerberg, E., Molin, C. J., Lindblad, I., Emtner, M. & Punga, A. R. Physical exercise in myasthenia gravis is safe and improves neuromuscular parameters and physical performance-based measures: A pilot study. Muscle Nerve. 56, 207\u2013214 (2017).","journal-title":"Muscle Nerve"},{"key":"42949_CR24","first-page":"1","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, 1\u20139 (2021).","journal-title":"BMJ"},{"key":"42949_CR25","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne, J. A. C. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366, l4898 (2019).","journal-title":"BMJ"},{"key":"42949_CR26","doi-asserted-by":"publisher","first-page":"108602","DOI":"10.1016\/j.envint.2024.108602","volume":"186","author":"JPT Higgins","year":"2024","unstructured":"Higgins, J. P. T. et al. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). Environ. Int. 186, 108602 (2024).","journal-title":"Environ. Int."},{"key":"42949_CR27","doi-asserted-by":"publisher","unstructured":"Sterne, J. A. et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ i4919. https:\/\/doi.org\/10.1136\/bmj.i4919 (2016).","DOI":"10.1136\/bmj.i4919"},{"key":"42949_CR28","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo, D., Wan, X., Liu, J. & Tong, T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat. Methods Med. Res. 27, 1785\u20131805 (2018).","journal-title":"Stat. Methods Med. Res."},{"key":"42949_CR29","unstructured":"Deeks, J. J., Higgins, J. P. T., Altman, D. G., McKenzie, J. E. & Veroniki, A. A. Chapter 10: Analysing data and undertaking meta-analyses. in Cochrane Handbook for Systematic Reviews of Interventions (eds Higgins, J. P. T. et al.) (Cochrane, 2024)."},{"key":"42949_CR30","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1007\/s12035-023-03247-5","volume":"60","author":"GM Tripathi","year":"2023","unstructured":"Tripathi, G. M., Misra, U. K., Kalita, J., Singh, V. K. & Tripathi, A. Effect of Exercise on \u03b2-Endorphin and Its Receptors in Myasthenia Gravis Patients. Mol. Neurobiol. 60, 3010\u20133019 (2023).","journal-title":"Mol. Neurobiol."},{"key":"42949_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nmd.2022.02.007","volume":"32","author":"JLS Thomsen","year":"2022","unstructured":"Thomsen, J. L. S., Vinge, L., Harbo, T. & Andersen, H. A population-based follow-up study of maximal muscle strength and mobility in patients with myasthenia gravis. Neuromuscul. Disord. 32, 305\u2013312 (2022).","journal-title":"Neuromuscul. Disord."},{"key":"42949_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/mus.26345","volume":"59","author":"Y Salci","year":"2019","unstructured":"Salci, Y. et al. Functional exercise capacity evaluated by timed walk tests in myasthenia gravis. Muscle Nerve. 59, 208\u2013212 (2019).","journal-title":"Muscle Nerve"},{"key":"42949_CR33","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3233\/JND-210637","volume":"8","author":"S Birnbaum","year":"2021","unstructured":"Birnbaum, S. et al. Free-Living Physical Activity and Sedentary Behaviour in Autoimmune Myasthenia Gravis: A Cross-Sectional Study. J. Neuromuscul. Dis. 8, 689\u2013697 (2021).","journal-title":"J. Neuromuscul. Dis."},{"key":"42949_CR34","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.nmd.2021.05.007","volume":"31","author":"LK Andersen","year":"2021","unstructured":"Andersen, L. K., Aadahl, M. & Vissing, J. Fatigue, physical activity and associated factors in 779 patients with myasthenia gravis. Neuromuscul. Disord. 31, 716\u2013725 (2021).","journal-title":"Neuromuscul. Disord."},{"key":"42949_CR35","first-page":"333","volume":"7","author":"T Deliana","year":"2025","unstructured":"Deliana, T., Poerwandari, D., Handajani, N. I., Sugianto, P. & Melaniani, S. Effect of low intensity aerobic cycling ergometer on muscle activation and muscle endurance of patients with myasthenia gravis in Dr. Soetomo General Hospital Surabaya. J. Med. Pharm. Chem. Res. 7, 333\u2013341 (2025).","journal-title":"J. Med. Pharm. Chem. Res."},{"key":"42949_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.37897\/RJMP.2024.1.14","volume":"19","author":"L Kartika","year":"2024","unstructured":"Kartika, L., Pawana, I. P. A., Arfianti, L. & Sugianto, P. Effect of low intensity aerobic cycle ergometer on maximal walking speed and cadence of myasthenia gravis patients. Romanian J. Med. Pract. 19, 16\u201321 (2024).","journal-title":"Romanian J. Med. Pract."},{"key":"42949_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.37897\/RJN.2024.1.1","volume":"23","author":"TD Putri","year":"2024","unstructured":"Putri, T. D. et al. Effect of low-intensity aerobic cycling ergometer on disease severity and depression of patients with myasthenia gravis in Dr. Soetomo General Hospital, Surabaya. Romanian J. Neurol. 23, 5\u201311 (2024).","journal-title":"Romanian J. Neurol."},{"key":"42949_CR38","doi-asserted-by":"publisher","first-page":"304","DOI":"10.37897\/RJN.2024.3.12","volume":"23","author":"I Muslihah","year":"2024","unstructured":"Muslihah, I., Meisy Andriana, R., Prawitri, Y. D., Sugianto, P. & Melaniani, S. Effect of low-intensity aerobic cycling ergometer on ability to perform activity of daily living of patients with myasthenia gravis in RSUD Dr. Soetomo Surabaya. Romanian J. Neurol. 23, 304\u2013310 (2024).","journal-title":"Romanian J. Neurol."},{"key":"42949_CR39","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/mus.25552","volume":"56","author":"MA Rahbek","year":"2017","unstructured":"Rahbek, M. A. et al. Exercise in myasthenia gravis: A feasibility study of aerobic and resistance training. Muscle Nerve. 56, 700\u2013709 (2017).","journal-title":"Muscle Nerve"},{"key":"42949_CR40","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.nmd.2021.05.002","volume":"31","author":"S Birnbaum","year":"2021","unstructured":"Birnbaum, S. et al. Home-based exercise in autoimmune myasthenia gravis: A randomized controlled trial. Neuromuscul. Disord. 31, 726\u2013735 (2021).","journal-title":"Neuromuscul. Disord."},{"key":"42949_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/JND-210722","volume":"9","author":"T Alsop","year":"2022","unstructured":"Alsop, T., Williams, K. & Gomersall, S. Physical Activity and Sedentary Behaviour in People with Myasthenia Gravis: A Cross-Sectional Study. J. Neuromuscul. Dis. 9, 137\u2013146 (2022).","journal-title":"J. Neuromuscul. Dis."},{"key":"42949_CR42","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.3390\/jcm10174031","volume":"10","author":"CC Chang","year":"2021","unstructured":"Chang, C. C., Chen, Y. K., Chiu, H. C. & Yeh, J. H. Changes in Physical Fitness and Body Composition Associated with Physical Exercise in Patients with Myasthenia Gravis: A Longitudinal Prospective Study. J. Clin. Med. 10, 4031 (2021).","journal-title":"J. Clin. Med."},{"key":"42949_CR43","doi-asserted-by":"crossref","unstructured":"Hsu, C. W. et al. Respiratory Muscle training improves functional outcomes and reduces fatigue in patients with myasthenia gravis: A single-center hospital\u2010based prospective study. Biomed. Res. Int. 2923907 (2020).","DOI":"10.1155\/2020\/2923907"},{"key":"42949_CR44","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1017\/S0317167100034077","volume":"25","author":"P Weiner","year":"1998","unstructured":"Weiner, P. et al. Respiratory Muscle Training in Patients With Moderate to Severe Myasthenia Gravis. Can. J. Neurol. Sci. \/ J. Canadien des. Sci. Neurologiques. 25, 236\u2013241 (1998).","journal-title":"Can. J. Neurol. Sci. \/ J. Canadien des. Sci. Neurologiques"},{"key":"42949_CR45","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.nmd.2007.01.001","volume":"17","author":"B Rassler","year":"2007","unstructured":"Rassler, B. et al. The effect of respiratory muscle endurance training in patients with myasthenia gravis. Neuromuscul. Disord. 17, 385\u2013391 (2007).","journal-title":"Neuromuscul. Disord."},{"key":"42949_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.rmed.2018.09.001","volume":"144","author":"S Freitag","year":"2018","unstructured":"Freitag, S., Hallebach, S., Baumann, I., Kalischewski, P. & Rassler, B. Effects of long-term respiratory muscle endurance training on respiratory and functional outcomes in patients with Myasthenia gravis. Respir Med. 144, 7\u201315 (2018).","journal-title":"Respir Med."},{"key":"42949_CR47","doi-asserted-by":"crossref","unstructured":"Rassler, B., Marx, G., Hallebach, S., Kalischewski, P. & Baumann, I. Long-term respiratory muscle endurance training in patients with myasthenia gravis: first results after four months of training. Autoimmune Dis. 1\u20137 (2011).","DOI":"10.4061\/2011\/808607"},{"key":"42949_CR48","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1378\/chest.128.3.1524","volume":"128","author":"GA Fregonezi","year":"2005","unstructured":"Fregonezi, G. A., de Resqueti, F., G\u00fcell, V. R., Pradas, R., Casan, P. & J. & Effects of 8-Week, Interval-Based Inspiratory Muscle Training and Breathing Retraining in Patients With Generalized Myasthenia Gravis. Chest 128, 1524\u20131530 (2005).","journal-title":"Chest"},{"key":"42949_CR49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000513668","volume":"84","author":"UK Misra","year":"2021","unstructured":"Misra, U. K. et al. Rest or 30-Min Walk as Exercise Intervention (RESTOREX) in Myasthenia Gravis: A Randomized Controlled Trial. Eur. Neurol. 84, 168\u2013174 (2021).","journal-title":"Eur. Neurol."},{"key":"42949_CR50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1615\/CritRevPhysRehabilMed.2021037593","volume":"33","author":"V Aupetitallot","year":"2021","unstructured":"Aupetitallot, V. & Franco, A. B. Effects of Physical Exercise on Functional and Respiratory Capacity, Quality of Life, and Fatigue Perception in Myasthenia Gravis Patients: A Systematic Review. Crit. Rev. Phys. Rehabil Med. 33, 87\u2013101 (2021).","journal-title":"Crit. Rev. Phys. Rehabil Med."},{"key":"42949_CR51","doi-asserted-by":"publisher","unstructured":"Wang, M., Wu, X., Jiao, Y., Yin, W. & Zhang, L. Life-Long Aerobic Exercise is a Non-Pharmacological Approach for Inducing Autophagy and Delaying Muscle Atrophy in the Aging Population. Aging Dis. https:\/\/doi.org\/10.14336\/AD.2024.0318 (2024).","DOI":"10.14336\/AD.2024.0318"},{"key":"42949_CR52","doi-asserted-by":"publisher","first-page":"8058","DOI":"10.3390\/ijms22158058","volume":"22","author":"SR Iyer","year":"2021","unstructured":"Iyer, S. R., Shah, S. B. & Lovering, R. M. The Neuromuscular Junction: Roles in Aging and Neuromuscular Disease. Int. J. Mol. Sci. 22, 8058 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"42949_CR53","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3390\/jcm11082189","volume":"11","author":"L Diez Porras","year":"2022","unstructured":"Diez Porras, L., Homedes, C., Alberti, M., Velez Santamaria, V. & Casasnovas, C. Quality of Life in Myasthenia Gravis and Correlation of MG-QOL15 with Other Functional Scales. J. Clin. Med. 11, 2189 (2022).","journal-title":"J. Clin. Med."},{"key":"42949_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jphys.2022.03.007","volume":"68","author":"N Shah","year":"2022","unstructured":"Shah, N., Shrivastava, M., Kumar, S. & Nagi, R. S. Supervised, individualised exercise reduces fatigue and improves strength and quality of life more than unsupervised home exercise in people with chronic Guillain-Barr\u00e9 syndrome: a randomised trial. J. Physiother. 68, 123\u2013129 (2022).","journal-title":"J. Physiother"},{"key":"42949_CR55","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3233\/JND-210677","volume":"9","author":"A Andries","year":"2022","unstructured":"Andries, A., Van Walsem, M. R., \u00d8rstavik, K. & Frich, J. C. Functional Ability and Physical Activity in Hereditary Neuromuscular Diseases. J. Neuromuscul. Dis. 9, 437\u2013446 (2022).","journal-title":"J. Neuromuscul. Dis."},{"key":"42949_CR56","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3233\/JND-170299","volume":"5","author":"ME Farrugia","year":"2018","unstructured":"Farrugia, M. E., Di Marco, M., Kersel, D. & Carmichael, C. A. Physical and Psychological Approach to Managing Fatigue in Myasthenia Gravis: A Pilot Study. J. Neuromuscul. Dis. 5, 373\u2013385 (2018).","journal-title":"J. Neuromuscul. Dis."},{"key":"42949_CR57","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3389\/fneur.2020.00675","volume":"11","author":"L O\u2019Connor","year":"2020","unstructured":"O\u2019Connor, L., Westerberg, E. & Punga, A. R. Myasthenia Gravis and Physical Exercise: A Novel Paradigm. Front. Neurol. 11, 675 (2020).","journal-title":"Front. Neurol."},{"key":"42949_CR58","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s11357-021-00510-2","volume":"44","author":"A Moreira-Pais","year":"2022","unstructured":"Moreira-Pais, A., Ferreira, R., Oliveira, P. A. & Duarte, J. A. A neuromuscular perspective of sarcopenia pathogenesis: deciphering the signaling pathways involved. Geroscience 44, 1199\u20131213 (2022).","journal-title":"Geroscience"},{"key":"42949_CR59","doi-asserted-by":"publisher","first-page":"101637","DOI":"10.1016\/j.rehab.2022.101637","volume":"66","author":"S Oorschot","year":"2023","unstructured":"Oorschot, S., Brehm, M. A., Daams, J., Nollet, F. & Voorn, E. L. Efficacy of aerobic exercise on aerobic capacity in slowly progressive neuromuscular diseases: A systematic review and meta-analysis. Ann. Phys. Rehabil Med. 66, 101637 (2023).","journal-title":"Ann. Phys. Rehabil Med."},{"key":"42949_CR60","doi-asserted-by":"crossref","unstructured":"Voet, N. B., van der Kooi, E. L., van Engelen, B. G. & Geurts, A. C. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst. Rev. (2019).","DOI":"10.1002\/14651858.CD003907.pub5"},{"key":"42949_CR61","doi-asserted-by":"crossref","unstructured":"Silva, I. S. et al. Respiratory muscle training in children and adults with neuromuscular disease. Cochrane Database Syst. Rev. CD011711 (2019).","DOI":"10.1002\/14651858.CD011711.pub2"},{"key":"42949_CR62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mus.27832","volume":"68","author":"B Claytor","year":"2023","unstructured":"Claytor, B., Cho, S. & Li, Y. Myasthenic crisis. Muscle Nerve. 68, 8\u201319 (2023).","journal-title":"Muscle Nerve"},{"key":"42949_CR63","doi-asserted-by":"crossref","unstructured":"O\u2019Connor, L., Westerberg, E. & Punga, A. R. Myasthenia gravis and physical exercise: A novel paradigm. Front. Neurol. 11, (2020).","DOI":"10.3389\/fneur.2020.00675"},{"key":"42949_CR64","doi-asserted-by":"publisher","first-page":"127","DOI":"10.55730\/1300-0144.5951","volume":"55","author":"A Teke\u015fi\u0307n","year":"2025","unstructured":"Teke\u015fi\u0307n, A. et al. Evaluation of nonmotor symptoms in myasthenia gravis patients. Turk. J. Med. Sci. 55, 127\u2013139 (2025).","journal-title":"Turk. J. Med. Sci."},{"key":"42949_CR65","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/09638288.2024.2338877","volume":"47","author":"T Alsop","year":"2025","unstructured":"Alsop, T., Cassimatis, M., Williams, K. L. & Gomersall, S. R. Perspectives of people with myasthenia gravis on physical activity and experience of physical activity advice from health professionals in the Australian context: a qualitative study. Disabil. Rehabil. 47, 156\u2013163 (2025).","journal-title":"Disabil. Rehabil"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42949-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42949-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42949-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:02:43Z","timestamp":1775797363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42949-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42949"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42949-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12004"}}